Research On The Strategic Development Of Yanji AoDong Pharmaceutical Co.,Ltd.

Pharmaceutical and health industry is a key sector of strategic emerging industries,and is one of the important components of the national economy,but also is included in the "Made in China 2025" Program of Action.The report of the 19th CPC National Congress clearly set out "Developing healthy industries,and,Implementing a healthy China strategy".This means that the healthy China strategy has risen to a new height,and the construction of healthy China has been upgraded to a national strategy.With the long-term economic consolidation and development of China’s economy,the comprehensive national strength continues to enhanced,the continuous improvement of the national living standards,China’s pharmaceutical and health industry is getting more and more attention,the huge market space of the pharmaceutical and health industry is further released,and related enterprises will also usher in new opportunities for development.In the face of good opportunities,enterprises are facing challenges and competition is extremely fierce.2018 is the key to the national health care reform,auxiliary medication discontinuation or set limit to limit the scope of use,and consistency evaluation of curative effect,deepen the reform of medical insurance directory adjustment,drug prices on the related pharmaceutical enterprise production mode,the mode of operation,technology research and development and product sales produced great influence on many aspects,bring a series of serious challenges.At the same time,the development of pharmaceutical industry in Jilin province has become a national and local focus in the past two years,which is of great significance to the development of local economyYanji Aodong pharmaceutical co.,LTD.,as a key industrial enterprises above designated size in Yanji City and Jilin Province,has a key role in supporting for the revitalization of northeast old industrial base and the overall development of the pharmaceutical industry of Jilin province.Despite more than 20 years of development,the company from the original bankruptcy of the small factory growth into an annual sales revenue exceeded 1 billion yuan,the tax to exceed 200 million yuan of enterprises,in China’s biopharmaceutical industry has a place.However,affected by macro,micro and other internal and external factors,they are also faced with a series of strategic management problems,such as controlling production costs,improving profit margins,optimizing talent structure and optimizing product structure,just like many pharmaceutical enterprises.Therefore,this paper takes Yanji Aodong pharmaceutical co.,LTD.as the research object,summarizes the current situation,problems and causes of strategic management of the enterprise through field research and data analysis,combined with strategic management theory,and proposes the development strategy and specific measures suitable for the enterprise.First of all,Yanji Aodong pharmaceutical co.,LTD.profile and development status evaluation.Secondly,it studies the problems and causes in the development of Yanji Aodong pharmaceutical co.,LTD.Thirdly,the strategic environment of Yanji Aodong pharmaceutical co.,LTD.Finally,the strategic objectives of Yanji Aodong pharmaceutical co.,LTD.,the selection of the corresponding development strategy,the formulation of the implementation plan,and the corresponding safeguard measures.This paper argues that Yanji Aodong pharmaceutical co.,LTD.should choose the compound strategy with the strengthening strategy as the main strategy and the cost leading strategy as the auxiliary strategy.To rely on the brand advantage of "Aodong",strengthen marketing efforts,to constantly improve the technological content of products,strengthen product innovation and research and development,create a strong product combination,the company should also improve the management level,build a strategic Management system,make it invincible.